WTW.jpg
WTW expands Asia Client Division – CRB N.A. with new China Client Division Leader for North America
September 27, 2024 11:18 ET | Willis Towers Watson US LLC
NEW YORK, Sept. 27, 2024 (GLOBE NEWSWIRE) -- WTW (NASDAQ: WTW), a leading global advisory, broking, and solutions company, today announced the launch of a new China Client Division within Corporate...
HorizonBancorpInc_SM.jpg
Horizon Bancorp, Inc. Announces Conference Call to Review Third Quarter 2024 Results on October 24
September 27, 2024 11:01 ET | Horizon Bancorp, Inc.
MICHIGAN CITY, Ind., September 26, 2024 (GLOBE NEWSWIRE) -- (NASDAQ GS: HBNC) – Horizon Bancorp, Inc. (“Horizon” or the “Company”) will host a conference c
Cytokinetics.png
Cytokinetics Presents Additional Data from SEQUOIA-HCM at the HCMS Scientific Sessions
September 27, 2024 11:00 ET | Cytokinetics, Incorporated
SOUTH SAN FRANCISCO, Calif., Sept. 27, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that additional data from SEQUOIA-HCM (Safety, Efficacy, and Quantitative...
Edible.jpg
Edible Garden Announces Pricing of $5.65 Million Public Offering
September 27, 2024 10:00 ET | Edible Garden AG Incorporated
BELVIDERE, N.J., Sept. 27, 2024 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA),...
Regeneron Logo.jpg
Dupixent® (dupilumab) Approved in the U.S. as the First-ever Biologic Medicine for Patients with COPD
September 27, 2024 09:35 ET | Regeneron Pharmaceuticals, Inc.
Dupixent is indicated for the approximately 300,000 adults in the U.S. with inadequately controlled chronic obstructive pulmonary disease (COPD) and an eosinophilic phenotype Following...
Qifu Technology Responds to Short Seller Report
September 27, 2024 09:27 ET | Qifu Technology, Inc.
SHANGHAI, China, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Qifu Technology, Inc. (NASDAQ: QFIN; HKEx: 3660) (“Qifu Technology” or the “Company”), a leading Credit-Tech platform in China, today issues the...
SYLA Technologies.jpg
SYLA Reports First-Half 2024 Financial and Operational Results
September 27, 2024 09:07 ET | SYLA Technologies Co., Ltd.
TOKYO, Sept. 27, 2024 (GLOBE NEWSWIRE) -- SYLA Technologies Co., Ltd. (NASDAQ: SYT) (“SYLA” or “the Company”), operator of the largest membership real estate crowd-funding platform in Japan,...
download.png
Altamira Therapeutics Announces Extended ISO 13485 Quality Management System Certification for Bentrio Nasal Spray
September 27, 2024 09:01 ET | Altamira Therapeutics Ltd
Hamilton, Bermuda, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Certification to ISO 13485 extended to also include production process  Supports Bentrio growth strategy together with strategic contract...
Color Star Technology Announces Pricing of Initial $7.0 Million Tranche of up to $33.0 Million Registered Senior Secured Convertible Notes
September 27, 2024 09:00 ET | Color Star Technology Co., Ltd.
NEW YORK, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Color Star Technology Co., Ltd. (Nasdaq: ADD) (“Color Star” or the “Company”), an entertainment technology company with a global network that focuses on...
Alumis.png
Late-Breaking Data at EADV of ESK-001, an Oral TYK2 Inhibitor for the Treatment of Psoriasis, Demonstrate Significant Responses with Sustained Increases Over 28 Weeks in Phase 2 OLE Study
September 27, 2024 09:00 ET | Alumis Inc.
Late breaking research presentation at EADV shows increasing and sustained responses in 28-week Phase 2 data for ESK-001 in psoriasis